Given that mitochondrial dysfunction far precedes neurodegeneration in this Mfn2 cKO model, our results clearly demonstrated that disrupted mitochondrial fusion could lead to neurodegeneration in AD-affected brain areas through mitochondrial dysfunction. This evidence concerns the gene MFN2 and Alzheimer disease.